Golden
A&G Pharmaceutical

A&G Pharmaceutical

A&G Pharmaceutical is a company deveoping personalized cancer therapeutics.

A&G Pharmaceutical is a biotechnology company developing personalized therapies for detecting and treating cancer and other human diseases that is headquartered in Columbia, Maryland and was founded in 2000 by Ginette Serrero, Gordon Sato, and Jun Hayashi.

Funding

Venture round

On April 27, 2010 A&G Pharmaceutical completed a venture capital round with $100,000 thousand in funding from undisclosed investors. 

Series A

On September 8, 2005 A&G Pharmaceutical completed their series A funding round with $2 million in funding from New England Partners (lead investor), Maryland Venture Fund, and Crocker Capital. 

Timeline

Funding rounds

1 Result
Funding round
Funding round
Funded company
Funded company
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date

A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement

Technology Networks

Web



NCI Awards A&G Pharmaceutical $2 million for Clinical Trial in Lung Cancer

PRWeb

Web



Documentaries, videos and podcasts

Title
Date
Link

A&G Pharmaceutical

November 1, 2012

A&G Pharmaceutical, Inc. "Developing Therapeutic & Diagnostic for Breast and Lung Cancers"

August 28, 2012

A&G Pharmaceutical: Fighting Cancer.avi

March 7, 2012

Companies

Company
CEO
Location
Products/Services









References